跳至主要内容
临床试验/EUCTR2022-002892-12-BE
EUCTR2022-002892-12-BE进行中(未招募)1 期

Comparison of the efficacy of ephedrine versus norepinephrine in the treatment of hypotension occurring after induction of general anesthesia in patients with chronic renal failure: randomized double-blind pilot study

CHU Brugmann0 个研究点目标入组 60 人开始时间: 2022年8月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
CHU Brugmann
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Age between 18 and 75 years old
  • Signed informed consent
  • Elective, non-cardiac surgery
  • General anaesthesia
  • Chronic renal failure with a GFR less than 45ml/min/m2 (stages below grade 3b and chronically on dialysis).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 25
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 35

排除标准

  • Congestive heart failure with LVEF < 50%
  • Moderate or severe cardiomyopathy or valvulopathy
  • History of atrial or ventricular arrhythmia
  • Taking drugs from the class of ACE inhibitors and sartans <24 hours before anesthesia
  • Chronic treatment with central antihypertensives such as a2 agonists
  • Chronic treatment with antidepressants of the following classes: selective norepinephrine reuptake inhibitors, tricyclic antidepressants, serotonin and norepinephrine reuptake inhibitors, norepinephrine and dopamine reuptake inhibitors, monoamine oxidase inhibitors.
  • BMI <18.5kg/m2 or >35kg/m2
  • ASA score = 4
  • Pregnant women
  • Allergy to a product used for anesthesia
  • Prone position required during surgery.

研究者

发起方
CHU Brugmann

相似试验